Is Tvardi Therapeutics TVRD stock breaking out Q4 2025 EPS Misses Estimates What level 2 data Celestica CLS 415 20260429 OXSQG Oxford posts Q1 2026 belowexpectation EPS shares climb 126 percent on positive investor sentiment Assembly Bio ASMB Stock Research Q4 2025 Better Than Expected Is Athene ATHS stock underperforming Is BioNexus Lab BGLC stock fading in strength SLNO Soleno Therapeutics tops Q4 2025 EPS estimates by 103 percent shares edge 021 percent lower today Can BillionToOne BLLN stock recover Q4 2025 Better Than Expected